All filters
Videos
Delivering research progress to patients: The researcher perspective | Phyllis Tien, MD
Presented at:
International Workshop on HIV & Aging 2017
Videos
Delivering research progress to patients: The community perspective | Jules Levin, MS
Presented at:
International Workshop on HIV & Aging 2017
Videos
Current reality: The New York experience | Eugenia Siegler, MD
Presented at:
International Workshop on HIV & Aging 2017
Videos
Current reality: The San Francisco experience | Meredith Greene, MD
Presented at:
International Workshop on HIV & Aging 2017
Videos
Exercise and aging | Wendy Kohrt, PhD
Presented at:
International Workshop on HIV & Aging 2017
Videos
OMICS in the context of aging and Alzheimer's disease | Madhav Thambisetty, MD
Presented at:
International Workshop on HIV & Aging 2017
Videos
The biology of superagers | Nir Barzilai, MD
Presented at:
International Workshop on HIV & Aging 2017
Videos
Clinical Trials Targeting Aging to Extend Healthy Lifespan | Jamie Justice, PhD
Presented at:
International Workshop on HIV & Aging 2017
Videos
Aramchol for NASH and beyond: From scientific rationale to clinical development | Carol Brosgart
Presented at:
HEP DART 2017
Videos
The Effectiveness of Treatment for Chronic Hepatitis C (and Hepatitis B) in Pediatric Populations | Manal El-Sayed, MD, PhD
Presented at:
HEP DART 2017
Videos
The Re-vival of Bile Acid Based Therapeutics for Children and Adults | Saul Karpen
Presented at:
HEP DART 2017
Videos
NASH Globally: Pathways to Combination Therapy, Biomarkers and Outcomes | Arun Sanyal
Presented at:
HEP DART 2017
Videos
Looking back to move forward: designing next-gen RNAi for best results in HBV | Bruce Given
Presented at:
HEP DART 2017
Videos
HEV Update: Diagnostics and Management | Kenneth Sherman, MD, PhD
Presented at:
HEP DART 2017
Videos
Revisiting the Molecular and Cell Biology of the Hepatitis B Virus Towards Elimination | Fabien Zoulim, MD, PhD
Presented at:
HEP DART 2017
Videos
Pan-genotypic direct-acting antiviral agents: Opportunity to achieve HCV elimination | Tarik Asselah
Presented at:
HEP DART 2017
Videos
DAA Controversies: Do they Cause HBV Reactivation and/or HCC? | Jordan Feld, MD, MPH
Presented at:
HEP DART 2017
Videos
SB 9200: A novel RIG-I agonist for chronic hepatitis B | Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)
Presented at:
HEP DART 2017
Videos
Development of Immune Competent Small Animal Models for HBV | Helene Strick-Marchand
Presented at:
HEP DART 2017
Videos
Core Antibody: anti-HBc What is the Core of the Story? | Robert Gish, MD
Presented at:
HEP DART 2017